Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4729-4745

  Schwab, Ute ^a,e   Abdullah, Lubna H ^a   Perlmutt, Olivia S ^a   Albert, Daniel ^b   William Davis, C ^a   Arnold, Roland R ^c   Yankaskas, James R ^a   Gilligan, Peter ^a   Neubauer, Heiner ^d   Randell, Scott H ^a   Boucher, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE; MUCIN; CULTURE MEDIUM;

ADOLESCENT; ADULT; ANAEROBIC GROWTH; ARTICLE; AUTOPSY; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; BREATHING; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS; CARBON SOURCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MIDDLE AGED; MIXED INFECTION; MUCUS; NONHUMAN; ORGANISMAL INTERACTION; PHAGOCYTE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; YOUNG ADULT; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTION; CHEMISTRY; CULTURE MEDIUM; CYSTIC FIBROSIS; LUNG; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION;

BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CULTURE MEDIA; CYSTIC FIBROSIS; HUMANS; LUNG; MUCUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84907960395     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01876-14     Document Type: Article

References (80)

1. Cystic Fibrosis Foundation. 2013. Cystic Fibrosis Foundation patient registry: 2012 annual data report. Cystic Fibrosis Foundation, Bethesda, MD.
2. Mahenthiralingam E, Urban TA, Goldberg JB. 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3:144-156. http://dx.doi.org/10.1038/nrmicro1085.
3. Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AGF, Wittmann R, Wilcox PG. 1999. Burkholderia cepacia in cystic fibrosis-variable disease course. Am. J. Respir. Crit. Care Med. 160:1572-1577.
4. Nielsen AT, Tolker-Nielsen T, Barken KB, Molin S. 2000. Role of commensal relationships on the spatial structure of a surface-attached microbial consortium. Environ. Microbiol. 2:59-68. http://dx.doi.org/10.1046/j.1462-2920.2000.00084.x.
5. Riedel K, Hentzer M, Geisenberger O, Huber B, Steidle A, Wu H, Høiby N, Givskov M, Molin S, Eberl L. 2001. N-Acylhomoserinelactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249-3262.
6. Bragonzi A, Farulla I, Paroni M, Twomey KB, Pirone L, Lorè NI, Bianconi I, Dalmastri C, Ryan RP, Bevivino A. 2012. Modelling coinfection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS One 7:e52330. http://dx.doi.org/10.1371/journal.pone.0052330.
7. Al-Bakri AG, Gilbert P, Allison DG. 2004. Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J. Appl. Microbiol. 96:455-463. http://dx.doi.org/10.1111/j.1365-2672.2004.02201.x.
8. Lam J, Chan R, Lam K, Costerton JW. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
9. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318.
10. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325. http://dx.doi.org/10.1172/JCI13870.
11. Ghani M, Soothill JS. 1997. Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Can. J. Microbiol. 43:999-1004. http://dx.doi.org/10.1139/m97-144.
12. Sriramulu DD, Lünsdorf H, Lam JS, Römling U. 2005. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 54:667-676. http://dx.doi.org/10.1099/jmm.0.45969-0.
13. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos J. 2010. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J. Med. Microbiol. 59:1089-1100. http://dx.doi.org/10.1099/jmm.0.019984-0.
14. Miller JK, Brantner JS, Clemons C, Kreider KL, Milsted A, Wilber P, Yun YH, Youngs WJ, Young G, Badawy HT, Milsted A, Clemons C, Kreider KL, Wilber P, Young G, Yun YH, Wagers PO, Youngs WJ. 2014. Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung. Math. Med. Biol. 31:179-204. http://dx.doi.org/10.1093/imammb/dqt003.
15. Huber B, Riedel K, Hentzer M, Heydorn A, Gotschlich A, Givskov M, Molin S, Eberl L. 2001. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147:2517-2528.
16. Conway BA, Venu V, Speert DP. 2002. Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J. Bacteriol. 184:5678-5585. http://dx.doi.org/10.1128/JB.184.20.5678-5685.2002.
17. Schwab U, Leigh M, Ribeiro C, Yankaskas J, Burns K, Gilligan P, Sokol P, Boucher R. 2002. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in human well-differentiated airway epithelia. Infect. Immun. 70:4547-4555. http://dx.doi.org/10.1128/IAI.70.8.4547-4555.2002.
18. Butler SL, Nelson JW, Poxton IR, Govan JR. 1994. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 8:285-292. http://dx.doi.org/10.1111/j.1574-695X.1994.tb00454.x.
19. Leelarasamee A. 1998. Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J. Trop. Med. Public Health 29:410-415.
20. Sajjan SU, Yang JH, Hershenson MB, LiPuma JJ. 2006. Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell. Microbiol. 8:1456-1466. http://dx.doi.org/10.1111/j.1462-5822.2006.00724.x.
21. Kaza SK, McClean S, Callaghan M. 2011. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int. J. Med. Microbiol. 301:26-33. http://dx.doi.org/10.1016/j.ijmm.2010.06.005.
22. Moura JA, Cristina de Assis M, Ventura GC, Saliba AM, Gonzaga L, Jr, Si-Tahar M, Marques EA, Plotkowski MC. 2008. Differential interaction of bacterial species from the Burkholderia cepacia complex with human airway epithelial cells. Microbes Infect. 10:52-59. http://dx.doi.org/10.1016/j.micinf.2007.10.002.
23. Duff C, Murphy PG, Callaghan M, McClean S. 2006. Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb. Pathog. 41:183-192. http://dx.doi.org/10.1016/j.micpath.2006.07.005.
24. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059.
25. Martin DW, Mohr CD. 2000. Invasion and intracellular survival of Burkholderia cepacia. Infect. Immun. 68:24-29. http://dx.doi.org/10.1128/IAI.68.1.24-29.2000.
26. Keig PM, Ingham E, Kerr KG. 2001. Invasion of human type II pneumocytes by Burkholderia cepacia. Microb. Pathog. 30:167-170. http://dx.doi.org/10.1006/mpat.2000.0418.
27. Saini LS, Galsworthy SB, John MA, Valvano MA. 1999. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145:3465-3475.
28. Lamothe J, Huynh KK, Grinstein S, Valvano MA. 2007. Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell. Microbiol. 9:40-53. http://dx.doi.org/10.1111/j.1462-5822.2006.00766.x.
29. Saldías MS, Valvano MA. 2009. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 155:2809-2817. http://dx.doi.org/10.1099/mic.0.031344-0.
30. Schmerk CL, Valvano MA. 2013. Burkholderia multivorans survival and trafficking within macrophages. J. Med. Microbiol. 62:173-184. http://dx.doi.org/10.1099/jmm.0.051243-0.
31. Sajjan U, Corey M, Humar A, Tullis E, Cutz E, Ackerley C, Forstner J. 2001. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J. Med. Microbiol. 50:535-546.
32. Sun L, Jiang RZ, Steinbach S, Holmes A, Campanelli C, Forstner J, Sajjan U, Tan Y, Riley M, Goldstein R. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1:661-666.
33. Stalon V, Mercenier A. 1984. L arginine utilization by Pseudomonas species. J. Gen. Microbiol. 130:69-76.
34. Verdoni N, Aon MA, Lebeault JM, Thomas D. 1990. Proton motive force, energy recycling by end product excretion, and metabolic uncoupling during anaerobic growth of Pseudomonas mendocina. J. Bacteriol. 172:6673-6681.
35. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock REW, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603. http://dx.doi.org/10.1016/S1534-5807(02)00295-2.
36. Galimand M, Gamper M, Zimmermann A, Haas D. 1991. Positive FNR-like control of anaerobic arginine degradation and nitrate respiration in Pseudomonas aeruginosa. J. Bacteriol. 173:1598-1606.
37. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. 2009. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17:130-138. http://dx.doi.org/10.1016/j.tim.2008.12.003.
38. Ribeiro CMP, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, O'Neal W, Boucher RC. 2005. Chronic airway infection/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J. Biol. Chem. 280:17798-17806. http://dx.doi.org/10.1074/jbc.M410618200.
39. Ribeiro CMP, Paradiso AM, Carew MA, Shears SB, Boucher RC. 2005. Cystic fibrosis airway epithelial Ca2+i signaling. The mechanism for the larger agonist-mediated Ca2+i signals in human cystic fibrosis airway epithelia. J. Biol. Chem. 280:10202-10209. http://dx.doi.org/10.1074/jbc.M410617200.
40. Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. 2005. Well-differentiated human airway epithelial cell cultures. Methods Mol. Med. 107:183-206.
41. Coakley RD, Grubb BR, Paradiso AM, Gatzy JT, Johnson LG, Kreda SM, O'Neal WK, Boucher RC. 2003. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc. Natl. Acad. Sci. U. S. A. 100:16083-16088. http://dx.doi.org/10.1073/pnas.2634339100.
42. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277. http://dx.doi.org/10.1128/JB.187.15.5267-5277.2005.
43. Hovenberg H, Davies JR, Carlstedt I. 1996. Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 318:319-324.
44. Wickstrom C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I. 1998. MUC5B is a major gel-forming, oligometric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334:685-693.
45. Sheehan JK, Brazeau C, Kutay S, Pigeon H, Kirkham S, Howard M, Thornton D. 2000. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucosal secretions. Biochem. J. 347:37-44. http://dx.doi.org/10.1042/0264-6021:3470037.
46. Abdullah LH, Davis SW, Burch L, Yamauchi M, Randell SH, Nettesheim P, Davis CW. 1996. P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem. J. 316:943-951.
47. Albert DB, Martens CS. 1997. Determination of low-molecular-weight organic acid concentrations in seawaterandpore-water samples viaHPLC.Mar. Chem. 56:27-33. http://dx.doi.org/10.1016/S0304-4203(96)00083-7.
48. Holmen JM, Karlsson NG, Abdullah LH, Randell SH, Sheehan JK, Hansson GC, Davis CW. 2004. Mucins and their O-glycans from human bronchial epithelial cell cultures. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L824-L834. http://dx.doi.org/10.1152/ajplung.00108.2004.
49. Sheehan JK, Boot-Handford RP, Chantler E, Carlstedt I, Thornton DJ. 1991. Evidence for shared epitopes within the 'naked' protein domains of human mucus glycoproteins. A study performed by using polyclonal antibodies and electron microscopy. Biochem. J. 274:293-296.
50. Baltimore RS, Christie CD, Smith GJ. 1989. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am. Rev. Respir. Dis. 140:1650-1661.
51. Sass AM, Schmerk C, Agnoli K, Norville PJ, Eberl L, Valvano MA, Mahenthiralingam E. 2013. The unexpected discovery of a novel low-oxygenactivated locus for the anoxic persistence of Burkholderia cenocepacia. ISME J. 7:1568-1581. http://dx.doi.org/10.1038/ismej.2013.36.
52. Gray T, Coakley R, Hirsh A, Thornton D, Kirkham S, Koo JS, Burch L, Boucher R, Nettesheim P. 2004. Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L320-L330. http://dx.doi.org/10.1152/ajplung.00440.2002.
53. Jansen HJ, Hart CA, Rhodes JM, Saunders JR, Smalley JW. 1999. A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa. J. Med. Microbiol. 48:551-557. http://dx.doi.org/10.1099/00222615-48-6-551.
54. Thornton DJ, Howard M, Khan N, Sheehan JK. 1997. Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J. Biol. Chem. 272:9561-9566.
55. Henderson AG, Ehre C, Button B, Abdullah LH, Cai LH, Leigh MW, DeMaria GC, Matsui H, Donaldson SH, Davis CW, Sheehan JK, Boucher RC, Kesimer M. 2014. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J. Clin. Invest. 124:3047-3060. http://dx.doi.org/10.1172/JCI73469.
56. Thornton DJ, Rousseau K, McGuckin MA. 2008. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 70:459-486. http://dx.doi.org/10.1146/annurev.physiol.70.113006.100702.
57. Zuelzer WW, Newton WA, Jr. 1949. The pathogenesis of fibrocystic disease of the pancreas. A study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4:53-69.
58. Matsui H, Wagner VE, Hill DB, Schwab UE, Rogers TD, Button B, Taylor RM, II, Superfine R, Rubinstein M, Iglewski BH, Boucher RC. 2006. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. U. S. A. 103:18131-18136. http://dx.doi.org/10.1073/pnas.0606428103.
59. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M. 2012. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337:937-941. http://dx.doi.org/10.1126/science.1223012.
60. Jørgensen KS, Tiedje JM. 1993. Survival of denitrifiers in nitrate-free, anaerobic environments. Appl. Environ. Microbiol. 59:3297-3305.
61. Leigh MW. 1999. Airway secretions, p 69-92. In Yankaskas JR, Knowles MR (ed), Cystic fibrosis in adults. Lippincott-Raven Publishers, Philadelphia, PA.
62. Strous GJ, Dekker J. 1992. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol. 27:57-92. http://dx.doi.org/10.3109/10409239209082559.
63. Rose MC, Voynow JA. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86:245-278. http://dx.doi.org/10.1152/physrev.00010.2005.
64. Macfarlane S, McBain AJ, Macfarlane GT. 1997. Consequences of biofilm and sessile growth in the large intestine. Adv. Dent. Res. 11:59-68. http://dx.doi.org/10.1177/08959374970110011801.
65. Haider K, Hossain A, Wanke C, Qadri F, Ali S, Nahar S. 1993. Production of mucinase and neuraminidase and binding of Shigella to intestinal mucin. J. Diarrhoeal Dis. Res. 11:88-92.
66. Smith AW, Chahal B, French GL. 1994. The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol. Microbiol. 13:153-160. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00410.x.
67. Houdret N, Ramphal R, Scharfman A, Perini JM, Filliat M, Lamblin G, Roussel P. 1989. Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection. Biochim. Biophys. Acta 992:96-105. http://dx.doi.org/10.1016/0304-4165(89)90055-X.
68. Leprat R, Michel-Briand Y. 1980. Extracellular neuraminidase production by a strain of Pseudomonas aeruginosa isolated from cystic fibrosis. Ann. Microbiol. (Paris) 131B:209-222.
69. Bernacki SH, Nelson AL, Abdullah L, Sheehan JK, Harris A, Davis CW, Randell SH. 1999. Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am. J. Respir. Cell Mol. Biol. 20:595-604. http://dx.doi.org/10.1165/ajrcmb.20.4.3442.
70. Moons P, Michiels CW, Aertsen A. 2009. Bacterial interactions in biofilms. Crit. Rev. Microbiol. 35:157-168. http://dx.doi.org/10.1080/10408410902809431.
71. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 47:738-745. http://dx.doi.org/10.1165/rcmb.2012-0088OC.
72. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. 2005. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 73:444-452. http://dx.doi.org/10.1128/IAI.73.1.444-452.2005.
73. Upritchard HG, Cordwell SJ, Lamont IL. 2008. Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins. Infect. Immun. 76:4624-4632. http://dx.doi.org/10.1128/IAI.01707-07.
74. Tomlin KL, Coll OP, Ceri H. 2001. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can. J. Microbiol. 47:949-954. http://dx.doi.org/10.1139/w01-095.
75. Waite RD, Curtis MA. 2009. Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J. Bacteriol. 191:1349-1354. http://dx.doi.org/10.1128/JB.01458-08.
76. Baron SS, Rowe JJ. 1981. Antibiotic action of pyocyanin. Antimicrob. Agents Chemother. 20:814-820. http://dx.doi.org/10.1128/AAC.20.6.814.
77. Parker WL, Rathnum ML, Seiner V, Trejo WH, Principe PA, Sykes RB. 1984. Cepacin A and cepacin B, two new antibiotics produced by Pseudomonas cepacia. J. Antibiot. (Tokyo) 37:431-440. http://dx.doi.org/10.7164/antibiotics.37.431.
78. Bakkal S, Robinson SM, Ordonez CL, Waltz DL, Riley MA. 2010. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156:2058-2067. http://dx.doi.org/10.1099/mic.0.036848-0.
79. Kresse AU, Dinesh SD, Larbig K, Romling U. 2003. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 47:145-158. http://dx.doi.org/10.1046/j.1365-2958.2003.03261.x.
80. Yang L, Jelsbak L, Molin S. 2011. Microbial ecology and adaptation in cystic fibrosis airways. Environ. Microbiol. 13:1682-1689. http://dx.doi.org/10.1111/j.1462-2920.2011.02459.x.